Table 4.
TIVAP-related complication rates in three groups.
| Complications | Group 1 (≤28 days, n = 133) | Group 2 (29–44 days, n = 350) | Group 3 (≥45 days, n = 80) | χ2 | P |
|---|---|---|---|---|---|
| Incomplete occlusion | 3 (2.26) | 4 (1.14) | 2 (2.50) | 1.24 | 0.54 |
| Complete occlusion | 0 (0) | 1 (0.29) | 1 (1.25) | 2.28 | 0.32 |
| Catheter malposition | 0 (0) | 0 (0) | 1 (1.25) | 4.10 | 0.14 |
| Port casing rotation | 0 (0) | 1 (0.29) | 0 (0) | 1.15 | 1.0 |
| Total | 3 (2.26) | 6 (1.72) | 4 (5.00) | 2.54 | 0.28 |
Note: Data are n (%), unless otherwise indicated. TIVAP = totally implantable venous access port.